These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 12457448

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
    Mayr B, Pötter E, Goretzki P, Rüschoff J, Dietmaier W, Hoang-Vu C, Dralle H, Brabant G.
    Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
    [Abstract] [Full Text] [Related]

  • 44. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
    Wang P, Wang YG, Zhao WJ, Fu YD, Wang L, Wang F, Zhao SH.
    Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
    [Abstract] [Full Text] [Related]

  • 45. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
    Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti MA.
    Cancer Res; 1994 Jun 01; 54(11):2979-85. PubMed ID: 8187085
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
    Zhu XL, Zhou XY, Zhang TM, Zhu XZ.
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb 01; 35(2):87-91. PubMed ID: 16630482
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. RET oncogene expression of papillary thyroid carcinoma in Korea.
    Chung KW, Chang MC, Noh DY, Oh SK, Choe KJ, Youn YK.
    Surg Today; 2004 Feb 01; 34(6):485-92. PubMed ID: 15170542
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
    Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M, Fusco A.
    Oncogene; 1995 Sep 21; 11(6):1207-10. PubMed ID: 7566982
    [Abstract] [Full Text] [Related]

  • 53. The ret/PTC oncogene in papillary thyroid carcinoma.
    Jhiang SM, Mazzaferri EL.
    J Lab Clin Med; 1994 Mar 21; 123(3):331-7. PubMed ID: 8133143
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.
    Musholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF, Klempnauer J.
    Surgery; 2000 Dec 21; 128(6):984-93. PubMed ID: 11114633
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].
    Koterov AN, Ushenkova LN, Biryukov AP.
    Radiats Biol Radioecol; 2016 Dec 21; 56(1):5-25. PubMed ID: 27245001
    [Abstract] [Full Text] [Related]

  • 59. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis.
    Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL.
    Laryngoscope; 1997 Jan 21; 107(1):95-100. PubMed ID: 9001272
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.